Serum levels of olanzapine and its N-desmethyl and 2-hydroxymethyl metabolites in child and adolescent psychiatric disorders: effects of dose, diagnosis, age, sex, smoking, and comedication.

Abstract:

:The aim of this study was to assess dose-related steady-state serum concentrations of olanzapine (OLZ) and its metabolites N-desmethyl OLZ (DMO) and 2-hydroxymethyl OLZ (2-OH-OLZ) (assessed by high-performance liquid chromatography) in 122 child and adolescent psychiatric patients (age 16.9 +/- 2.2, range, 10-21 years; 74 males, 48 females) with a variety of diagnoses: schizophrenia group (n = 80); nonschizophrenia group (n = 29); anorexia nervosa (AN) group (n = 13). Median OLZ serum concentrations were 32.7 (range, 1-118; all patients), 37.7 (2-115; schizophrenia group), and 18.7 (1-63, AN group) ng/mL. The median OLZ concentration-to-dose (C/D) ratio (n = 122) was 2.6, with 90% of the distribution between 0.8 and 5.5 (ng/mL)/(mg/d). OLZ concentration was significantly correlated with DMO (r = 0.567; P < 0.0005) but not with 2-OH-OLZ (r = 0.122; P = 0.188). Daily OLZ dose was correlated with OLZ concentration in all (r = 0.684; P < 0.0005), schizophrenic (r = 0.542; P < 0.0005), and AN (r = 0.805; P = 0.001) patients, respectively. Patients aged less than 16 years displayed similar C/D for OLZ (P = 0.58) but higher C/D for DMO (P = 0.003) than those 16 years or older. AN patients received lower median OLZ doses (7.5; 5-15 mg) than schizophrenic patients (12.5; 2.5-40 mg), even after correcting for body mass index (P = 0.02). OLZ dose did not differ (P = 0.088) between smokers and nonsmokers, but smokers showed lower C/D for OLZ than nonsmokers (P = 0.008). C/D for OLZ was 38% higher (P = 0.041) under comedication with selective serotonin reuptake inhibitors when compared with OLZ monotherapy. Multiple linear regression analysis revealed that 46% of the variation of OLZ concentration can be explained by dose, diagnosis, age, sex, smoking, and comedication. The data are compared with the literature, and the relevance of therapeutic antipsychotic drug monitoring in previously sparsely investigated subgroups, such as children and adolescents or patients with AN, is emphasized.

journal_name

Ther Drug Monit

authors

Theisen FM,Haberhausen M,Schulz E,Fleischhaker C,Clement HW,Heinzel-Gutenbrunner M,Remschmidt H

doi

10.1097/01.ftd.0000249950.75462.7f

subject

Has Abstract

pub_date

2006-12-01 00:00:00

pages

750-9

issue

6

eissn

0163-4356

issn

1536-3694

pii

00007691-200612000-00005

journal_volume

28

pub_type

杂志文章
  • Pharmacokinetic Variability and Clinical Use of Lacosamide in Children and Adolescents in Denmark and Norway.

    abstract:BACKGROUND:The indication for the antiepileptic drug lacosamide (LCM) was recently extended to include children from the age of 4 years. Real-life data on the use and serum concentrations of LCM in children and adolescents are limited. The purpose of this study was to investigate the use of LCM in this patient group in...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/FTD.0000000000000599

    authors: Larsen Burns M,Nikanorova M,Baftiu A,Borg Rasmussen J,Johannessen SI,Johannessen Landmark C

    更新日期:2019-06-01 00:00:00

  • Evaluation of therapeutic drug monitoring of methotrexate in saliva of children with rheumatic diseases.

    abstract::Pediatric patients with leukemia, other malignancies, and rheumatological disease receive methotrexate chronically. Because of the documented correlation between methotrexate levels of compliance and clinical outcome, it is conceivable to verify appropriate systemic exposure to the drug. Saliva sampling may be of pote...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/00007691-199506000-00006

    authors: Press J,Berkovitch M,Laxer R,Giesbrecht E,Verjee Z,Silverman E,Klein J,Koren G

    更新日期:1995-06-01 00:00:00

  • Carbamazepine and its epoxide: an open study of efficacy and side effects after carbamazepine dose increment in refractory partial epilepsy.

    abstract::We evaluated the efficacy, development of adverse effects, and possible correlation between the plasma concentration of carbamazepine (CBZ) and its major metabolite, carbamazepine-10,11-epoxide (CBZ-E), in a group of epileptic patients in whom selective increases in CBZ doses were made. Eighteen patients with refracto...

    journal_title:Therapeutic drug monitoring

    pub_type: 临床试验,杂志文章

    doi:

    authors: Semah F,Gimenez F,Longer E,Laplane D,Thuillier A,Baulac M

    更新日期:1994-12-01 00:00:00

  • Immunoassays for Measuring Serum Concentrations of Monoclonal Antibodies and Anti-biopharmaceutical Antibodies in Patients.

    abstract::Monoclonal antibodies (mAbs) may be used as biopharmaceuticals to treat various diseases, ranging from oncology to inflammatory and cardiovascular affections. Trustworthy analytical methods are necessary to study their pharmacokinetics, both during their development and in post-marketing studies. Because biopharmaceut...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章,评审

    doi:10.1097/FTD.0000000000000419

    authors: Darrouzain F,Bian S,Desvignes C,Bris C,Watier H,Paintaud G,de Vries A

    更新日期:2017-08-01 00:00:00

  • The pharmacokinetics of enteric-coated mycophenolate sodium and its gastrointestinal side effects in de novo renal transplant recipients of Hispanic ethnicity.

    abstract:OBJECTIVE:The aim of the study is to characterize the pharmacokinetics and the gastrointestinal side effect profiles of enteric-coated mycophenolate sodium (EC-MPS) in de novo kidney transplant patients of Hispanic ethnicity. MATERIALS AND METHODS:The pharmacokinetic study of EC-MPS was conducted in 11 de novo kidney ...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/FTD.0b013e31820271c3

    authors: Shah T,Tellez-Corrales E,Yang JW,Qazi Y,Wang J,Wilson J,Hutchinson I,Min DI

    更新日期:2011-02-01 00:00:00

  • Michaelis-Menten kinetics and the steady-state serum phenytoin/hydroxyphenytoin ratio.

    abstract::The effect of nonlinear kinetics on the steady-state ratio of serum phenytoin (PHT) to total 5-(p-hydroxyphenyl)-5-phenylhydantoin (p-HPPH) was studied in epileptic patients. In each patient, the ratio increased in a nonlinear fashion in relation to both the PHT dose and the PHT serum level. Patients with longer appar...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/00007691-198512000-00007

    authors: Bourgeois BF,Wad N

    更新日期:1985-01-01 00:00:00

  • Overview of FTY720 clinical pharmacokinetics and pharmacology.

    abstract::Drug discovery programs are actively exploring for therapeutic agents targeting enzymes and receptors regulating sphingolipid metabolism and biologic functions. FTY720 is a close structural analogue of sphingosine with immunomodulatory properties. After oral administration, FTY720 is phosphorylated by sphingosine kina...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章,评审

    doi:10.1097/00007691-200412000-00001

    authors: Kovarik JM,Schmouder RL,Slade AJ

    更新日期:2004-12-01 00:00:00

  • Validation of an assay for voriconazole in serum samples using liquid chromatography-tandem mass spectrometry.

    abstract::A simple and rapid liquid chromatography tandem mass spectrometry (HPLC-MS/MS) method for the analysis of voriconazole has been developed. For comparison, serum voriconazole was measured using HPLC and bioassay. For the HPLC-MS/MS assay, samples were prepared in a deep-well block by adding 10 microL of serum to 40 mic...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/00007691-200412000-00011

    authors: Keevil BG,Newman S,Lockhart S,Howard SJ,Moore CB,Denning DW

    更新日期:2004-12-01 00:00:00

  • Within-patient variability of mycophenolic acid exposure: therapeutic drug monitoring from a clinical point of view.

    abstract::Exposure to mycophenolic acid (MPA) is highly variable among patients on standard dose mycophenolate mofetil (MMF) therapy. In addition, MPA exposure increases with time posttransplant and exposure is predictive for the development of acute rejection. Consequently, therapeutic drug monitoring (TDM) of MPA may improve ...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章,评审

    doi:10.1097/01.ftd.0000194504.62892.b2

    authors: van Hest RM,Mathot RA,Vulto AG,Ijzermans JN,van Gelder T

    更新日期:2006-02-01 00:00:00

  • South Africa: a toxicologist's goldmine.

    abstract::The emerging nation of South Africa, in common with some other countries, notably Eastern Europe, is heir to decades of neglect with regards to the exposure of the majority of its population to toxic materials. In this short review, the major toxic health hazards are described. For most of these risks there are now pr...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章,评审

    doi:10.1097/00007691-200202000-00027

    authors: Stewart MJ

    更新日期:2002-02-01 00:00:00

  • Generic Olanzapine Substitution in Patients With Schizophrenia: Assessment of Serum Concentrations and Therapeutic Response After Switching.

    abstract:BACKGROUND:Several reports of loss of efficacy or adverse effects have been described after generic substitution of antipsychotics. To date, studies comparing serum drug levels in patients switched to generic antipsychotics in a standard clinical setting are lacking. The aim of this study was to investigate if switchin...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/FTD.0000000000000211

    authors: Italiano D,Bruno A,Santoro V,Lanza G,Muscatello MR,Zoccali R,Spina E

    更新日期:2015-12-01 00:00:00

  • Therapeutic drug monitoring of infliximab in spondyloarthritis: an observational open-label study.

    abstract:BACKGROUND:Infliximab is a chimeric monoclonal antibody that binds to human tumor necrosis factor alpha and which is approved for refractory spondyloarthritis (SpA). Individual adjustment of infliximab dosage may help to improve the therapeutic response in SpA. We investigated whether a knowledge of infliximab serum co...

    journal_title:Therapeutic drug monitoring

    pub_type: 临床试验,杂志文章

    doi:10.1097/FTD.0b013e318224f83d

    authors: Méric JC,Mulleman D,Ducourau E,Lauféron F,Miow Lin DC,Watier H,Goupille P,Paintaud G

    更新日期:2011-08-01 00:00:00

  • Comparison of three immunoassays for the determination of N-acetylprocainamide. Determination of false elevations by a polyclonal antibody-based method.

    abstract::The performance of the ROCHE FP NAPA reagent, a newly reformulated monoclonal antibody-based fluorescence polarization immunoassay (FPIA) for N-acetylprocainamide, was compared with two commercially available polyclonal antibody-based immunoassays, the Abbott TDx and Syva EMIT. Although excellent correlation was obser...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/00007691-199406000-00013

    authors: Laurino JP,McKay J,Fischberg E,Schwenzer K,Kaufman R

    更新日期:1994-06-01 00:00:00

  • Ability of three pharmacokinetic equations to predict steady-state serum theophylline concentrations in pediatric patients.

    abstract::The pharmacokinetic equations of Chiou, Koup, and Kurland are often used in the pediatric setting to predict steady-state theophylline clearance using non-steady serum theophylline concentrations. However, these equations have not been validated or compared in a pediatric population. We evaluated the ability of these ...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/00007691-199210000-00002

    authors: Reiter PD,Hogue SL,Phelps SJ

    更新日期:1992-10-01 00:00:00

  • Dose adjustment strategy for oral microemulsion formulation of cyclosporine: population pharmacokinetics-based analysis in kidney transplant patients.

    abstract::The present study aims to determine the population pharmacokinetic parameters of cyclosporine (CsA) after multiple oral administration of the microemulsion formulation, Neoral, in kidney transplant patients and to propose a limited sampling strategy to predict AUC(0-4h) using them and the Bayesian method. The AUC(0-4h...

    journal_title:Therapeutic drug monitoring

    pub_type: 临床试验,杂志文章

    doi:10.1097/00007691-200406000-00012

    authors: Tokui K,Kimata T,Uchida K,Yuasa H,Hayashi Y,Itatsu T,Nabeshima T

    更新日期:2004-06-01 00:00:00

  • Population Pharmacokinetic Analysis of Phenytoin After Intravenous Administration of Fosphenytoin in Adult and Elderly Epileptic Patients.

    abstract:BACKGROUND:Fosphenytoin, the diphosphate ester salt of phenytoin, is widely used to treat status epilepticus. The aim of this study was to develop a population pharmacokinetic (PPK) model to describe serum phenytoin concentrations after the intravenous administration of fosphenytoin in adult and elderly epileptic patie...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/FTD.0000000000000651

    authors: Higuchi K,Yamashita D,Kashihara Y,Kakara M,Hirota T,Hirakawa M,Ieiri I

    更新日期:2019-10-01 00:00:00

  • Therapeutic drug monitoring of common antipsychotics.

    abstract::The aim of this review is to provide information for interpreting outcome results from monitoring of antipsychotics in biological samples. A brief overview of the working mechanisms, pharmacological effects, drug interactions, and analytical methods of classical and atypical antipsychotics is given. Nineteen antipsych...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章,评审

    doi:10.1097/FTD.0b013e3182708ec5.

    authors: Patteet L,Morrens M,Maudens KE,Niemegeers P,Sabbe B,Neels H

    更新日期:2012-12-01 00:00:00

  • Alarming prevalence of fetal alcohol exposure in a Mediterranean city.

    abstract::The prevalence of gestational ethanol exposure and subsequent fetal exposure has been assessed in a cohort of mother-infant dyads in a Mediterranean city (Barcelona, Spain) by meconium analysis of fatty acid ethyl esters (FAEEs) after showing in this population a high prevalence of meconium opiates (8.7%), cocaine (4....

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/FTD.0b013e31816a8657

    authors: Garcia-Algar O,Kulaga V,Gareri J,Koren G,Vall O,Zuccaro P,Pacifici R,Pichini S

    更新日期:2008-04-01 00:00:00

  • Is free fraction measurement of phenytoin always necessary in pediatric epileptic patients?

    abstract::Sixty-two serum samples from 28 pediatric epileptic patients under treatment with phenytoin [diphenylhydantoin (DPH)] were obtained to study the correlation between total and free serum DPH concentrations. The effect of coadministered antiepileptic drugs on DPH protein binding was also studied. Binding of DPH to serum...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:

    authors: Johno I,Kuzuya T,Suzuki K,Hasegawa M,Nakamura T,Kitazawa S,Aso K,Watanabe K

    更新日期:1988-01-01 00:00:00

  • Cost-effectiveness of therapeutic drug monitoring: a systematic review.

    abstract::There are a number of effective but highly toxic drugs that exhibit a narrow therapeutic index and marked interpatient pharmacokinetic variability. Individualized therapy with such drugs requires therapeutic drug monitoring (TDM) to obtain the desired clinical effects safely. Cost-effectiveness analysis in health care...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章,评审

    doi:10.1097/00007691-200502000-00004

    authors: Touw DJ,Neef C,Thomson AH,Vinks AA,Cost-Effectiveness of Therapeutic Drug Monitoring Committee of the International Association for Therapeutic Drug Monitoring and Clinical Toxicology.

    更新日期:2005-02-01 00:00:00

  • Pharmacokinetics of cocaine and metabolites in human oral fluid and correlation with plasma concentrations after controlled administration.

    abstract:UNLABELLED:Oral fluid is an attractive alternative matrix for drug testing with a noninvasive and directly observed collection, but there are few controlled cocaine administration studies to guide interpretation. MATERIALS AND METHODS:While residing on a closed research unit for up to 10 weeks under constant medical s...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/FTD.0b013e3181f2b729

    authors: Scheidweiler KB,Spargo EA,Kelly TL,Cone EJ,Barnes AJ,Huestis MA

    更新日期:2010-10-01 00:00:00

  • Effects of smoking on nortriptyline plasma concentrations in depressed patients.

    abstract::The pharmacokinetic parameters of half-life, volume of distribution, and steady-state nortriptyline plasma concentration normalized to a 100-mg/day maintenance dose were calculated in nine smokers and 15 nonsmokers. The mean normalized total nortriptyline concentration for the smokers of 118 +/- 33 ng/ml was significa...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/00007691-198609000-00007

    authors: Perry PJ,Browne JL,Prince RA,Alexander B,Tsuang MT

    更新日期:1986-01-01 00:00:00

  • New modified fluorescence polarization immunoassay does not falsely elevate vancomycin concentrations in patients with end-stage renal disease.

    abstract::Recent literature has urged caution in the interpretation of vancomycin serum concentrations in patients with end-stage renal disease (ESRD), because falsely elevated levels in excess of 70% have been reported with the most commonly used fluorescence polarization immunoassay (FPIA). The purpose of this study was to ev...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/00007691-199804000-00016

    authors: Smith PF,Petros WP,Soucie MP,Copeland KR

    更新日期:1998-04-01 00:00:00

  • Effects of hepatic function on vancomycin pharmacokinetics in patients with cancer.

    abstract::Vancomycin is widely used in the prophylaxis and treatment of infections in neutropenic patients with cancer. The objective of this study was to analyze liver damage effects on vancomycin pharmacokinetics and determine the necessity for liver function evaluation when selecting vancomycin dosing schedules in these pati...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/00007691-200006000-00004

    authors: Aldaz A,Ortega A,Idoate A,Giráldez J,Brugarolas A

    更新日期:2000-06-01 00:00:00

  • Time course of appearance of cotinine in human beard hair after a single dose of nicotine.

    abstract::The time course of appearance of cotinine in saliva and in daily collections of beard clippings was monitored by gas chromatography with mass spectrometry in six volunteers who were nonsmokers following a single 30-min buccal administration of nicotine as a chewing gum. Salivary cotinine concentrations reached a plate...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/00007691-199504000-00016

    authors: Gwent SH,Wilson JF,Tsanaclis LM,Wicks JF

    更新日期:1995-04-01 00:00:00

  • Efficiency and Safety of an Early Dose Adjustment of Ribavirin in Patients Infected With Hepatitis C Underexposed to the Drug and Treated With Peginterferon Ribavirin.

    abstract:BACKGROUND:Ribavirin exposure after the first dose (D0AUC0-4h) >1755 mcg·h·L is predictive of sustained virological response (SVR) in patients with hepatitis C treated with peginterferon and ribavirin. The aim of this study was to test the benefit of ribavirin early dose adjustment based on this target in naïve patient...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1097/FTD.0000000000000332

    authors: Loustaud-Ratti V,Maynard M,Thevenon S,Pradat P,Rousseau A,Alain S,Deny P,Gagnieu MC,Tran A,Dao T,Silvain C,Lunel-Fabiani F,Picard N,Zublena I,Marquet P,Trepo C,RIBAJUSTE Group.

    更新日期:2016-12-01 00:00:00

  • Population pharmacokinetics of intravenous, intramuscular, and intranasal naloxone in human volunteers.

    abstract::To investigate the pharmacokinetics of naloxone in healthy volunteers, we undertook an open-label crossover study in which six male volunteers received naloxone on five occasions: intravenous (0.8 mg), intramuscular (0.8 mg), intranasal (0.8 mg), intravenous (2 mg), and intranasal (2 mg). Samples were collected for 4 ...

    journal_title:Therapeutic drug monitoring

    pub_type: 临床试验,杂志文章

    doi:10.1097/FTD.0b013e3181816214

    authors: Dowling J,Isbister GK,Kirkpatrick CM,Naidoo D,Graudins A

    更新日期:2008-08-01 00:00:00

  • Bayesian pharmacokinetic/pharmacodynamic forecasting of prothrombin response to warfarin therapy: preliminary evaluation.

    abstract::The ability of a pharmacokinetic/pharmacodynamic Bayesian forecasting computer program to predict prothrombin response to warfarin therapy was investigated. The performance of the program was evaluated retrospectively in an inpatient study population of 45 subjects. Predictions of prothrombin response at discharge, ba...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/00007691-198506000-00006

    authors: Svec JM,Coleman RW,Mungall DR,Ludden TM

    更新日期:1985-01-01 00:00:00

  • Determination of amprenavir total and unbound concentrations in plasma by high-performance liquid chromatography and ultrafiltration.

    abstract::Amprenavir is an HIV-1 protease inhibitor with high protein binding (90%) in human plasma. This study was designed to develop an assay to measure the concentration of unbound amprenavir, to study variation with time in patients, and to investigate whether ritonavir and lopinavir, other protease inhibitors that could b...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/01.ftd.0000188018.26680.98

    authors: Barrail A,Le Tiec C,Paci-Bonaventure S,Furlan V,Vincent I,Taburet AM

    更新日期:2006-02-01 00:00:00

  • Screening procedure for detection of diuretics and uricosurics and/or their metabolites in human urine using gas chromatography-mass spectrometry after extractive methylation.

    abstract::A gas chromatography-mass spectrometry (GC-MS)-based screening procedure was developed for the detection of diuretics, uricosurics, and/or their metabolites in human urine after extractive methylation. Phase-transfer catalyst remaining in the organic phase was removed by solid-phase extraction on a diol phase. The com...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/01.ftd.0000160719.96445.91

    authors: Beyer J,Bierl A,Peters FT,Maurer HH

    更新日期:2005-08-01 00:00:00